Suven gets second product patent in US
According to the invention of this patent disclosure, the compounds are useful in the treatment of neurodegenerative disorders like Alzheimer’s, Parkinson, Schizophrenia and Huntington’s. Venkat Jasti, CEO of
miRecule has signed a research collaboration with EM subsidiary Rio Biofarma Brasil (RBBL) to co-develop peptide-mediated delivery technologies aimed at improving targeted ribonucleic acid (RNA) therapeutics delivery to tissues beyond the liver and muscles in a range of disease areas.